3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioma
7
Wilms Tumor
6
Rhabdoid Tumor
5
Osteosarcoma
5
Neuroectodermal Tumors, Primitive, Peripheral
5
Neuroblastoma
5
Multiple Myeloma
5
Medulloblastoma
5
Lymphoma, Non-Hodgkin
5
Leukemia, Myeloid, Acute
5
Histiocytosis, Langerhans-Cell
5
Hepatoblastoma
5
Ependymoma
5
Sarcoma
4
Rhabdomyosarcoma
4
Lymphoma
4
Lung Neoplasms
4
Central Nervous System Neoplasms
4
Burkitt Lymphoma
4
Breast Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Myelodysplastic Syndromes
3
Urinary Bladder Neoplasms
2
Sarcoma, Ewing
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Neuroendocrine Tumors
2
Mycosis Fungoides
2
Melanoma
2
Malignant Solid Neoplasm
2
Interventions
Cyclophosphamide
8
fludarabine phosphate
6
fludarabine
6
pembrolizumab
5
Whole-Body Irradiation
5
Vinblastine
5
Nivolumab
5
Granulocyte Colony-Stimulating Factor
5
Filgrastim
5
Doxorubicin
5
Dacarbazine
5
Mycophenolic Acid
4
Melphalan
4
Magnetic Resonance Spectroscopy
4
Brentuximab Vedotin
4
pegfilgrastim
3
Peripheral Blood Stem Cell Transplantation
3
Etoposide
3
Cyclosporine
3
Busulfan
3
Tacrolimus
2
Radiotherapy
2
Fluorodeoxyglucose F18
2
Azacitidine
2
Antilymphocyte Serum
2
treosulfan
1
tocilizumab
1
thymoglobulin
1
tafasitamab
1
selinexor
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hodgkin Disease
×
X-Rays
×
30 days
×
Clear all
No trials found.